Acima Private Wealth’s DexCom DXCM Stock Holding History

Acima Private Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200	Closed	-$23.2K	–	267
2023 Q1	$23.2K	Hold	200	–	–	0.01%	189
2022 Q4	$22.6K	Hold	200	–	–	0.01%	178
2022 Q3	$16.1K	Hold	200	–	–	0.01%	188
2022 Q2	$14.9K	Hold	200	–	–	0.01%	199
2022 Q1	$26K	Hold	200	–	–	0.01%	187
2021 Q4	$27K	Hold	200	–	–	0.01%	189
2021 Q3	$27K	Hold	200	–	–	0.01%	178
2021 Q2	$21K	Hold	200	–	–	0.01%	187
2021 Q1	$18K	Hold	200	–	–	0.01%	188
2020 Q4	$18K	Hold	200	–	–	0.01%	187
2020 Q3	$21K	Hold	200	–	–	0.01%	180
2020 Q2	$20K	Hold	200	–	–	0.01%	200
2020 Q1	$13K	Hold	200	–	–	0.01%	213
2019 Q4	$11K	Hold	200	–	–	0.01%	241
2019 Q3	$7K	Hold	200	–	–	0.01%	236
2019 Q2	$7K	Hold	200	–	–	0.01%	213
2019 Q1	$6K	Hold	200	–	–	0.01%	214
2018 Q4	$6K	Buy	+200	New	+$6.34K	0.01%	222

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Acima Private Wealth's DXCM Position: Q2 2023 in Review

Acima Private Wealth sold out of DexCom (DXCM) in Q2 2023, closing a stake of 200 shares — an estimated $23.2K sold.

Acima Private Wealth first reported a position in DXCM in Q4 2018 and held it in 18 quarters. The position peaked at $27K in Q4 2021. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

Acima Private Wealth reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
Acima Private Wealth sold 200 DexCom shares in Q2 2023, an estimated $23.2K.
Acima Private Wealth first reported a position in DexCom in Q4 2018 and held it in 18 quarters.
Acima Private Wealth's DexCom position peaked at $27K in Q4 2021.
954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on Acima Private Wealth's 13F filing for Q2 2023, filed 29 Feb 2024.